Cargando…
Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects
BACKGROUND: Evidence has accumulated demonstrating the existence of opioid receptor heteromers, and recent data suggest that targeting these heteromers could reduce opioid side effects while retaining therapeutic effects. Indeed, CYM51010 characterized as a MOR (mu opioid receptor)/DOR (delta opioid...
Autores principales: | Requana Aradas, Ariadna, Djaboub, Youssra, McCort-Tranchepain, Isabelle, Hajasova, Zuzana, Clémenceau, Loïc, Canestrelli, Corinne, Mann, Anika, Schulz, Stefan, Delaval, Angélique, Acher, Francine, Massotte, Dominique, Noble, Florence, Marie, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388387/ https://www.ncbi.nlm.nih.gov/pubmed/37343217 http://dx.doi.org/10.1093/ijnp/pyad032 |
Ejemplares similares
-
Conformational pathway provides unique sensitivity to a synaptic mGluR
por: Habrian, Chris H., et al.
Publicado: (2019) -
Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
por: Ong, Edmund W., et al.
Publicado: (2014) -
Morphine-Induced Dendritic Spine Remodeling in Rat Nucleus Accumbens Is Corticosterone Dependent
por: Geoffroy, Hélène, et al.
Publicado: (2019) -
Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism
por: Milan-Lobo, Laura, et al.
Publicado: (2013) -
Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers
por: Fujita, Wakako, et al.
Publicado: (2014)